Fractyl Health (GUTS) Free Cash Flow (2023 - 2026)
Fractyl Health's (GUTS) quarterly Free Cash Flow came in at -$22.5 million in Q1 2026, up 11.95% YoY from -$20.1 million in Q1 2025, and down 5.33% on a QoQ basis from -$21.3 million in Q4 2025.
Fractyl Health (GUTS) Free Cash Flow (2023 - 2026) Analysis & Trends
Fractyl Health (GUTS) has 4 years of Free Cash Flow data on file, last reported at -$22.5 million in Q1 2026.
- Quarterly Free Cash Flow rose 11.95% year-over-year to -$22.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$87.8 million (down 8.33% YoY) and the FY2025 annual result came in at -$90.9 million, down 35.07% from the prior year.
- Free Cash Flow eased to -$22.5 million in Q1 2026, from -$21.3 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$9.6 million in Q1 2023 to a low of -$25.5 million in Q1 2025.
- A 4-year average of -$17.2 million and a median of -$18.3 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2025 — Free Cash Flow tumbled 117.6% — and 2026, when it rose 11.95%.
- Tracing GUTS's Free Cash Flow over 4 years: stood at -$10.7 million in 2023, then slumped by 61.84% to -$17.3 million in 2024, then dropped by 23.58% to -$21.3 million in 2025, then declined by 5.33% to -$22.5 million in 2026.
- The last three Free Cash Flow figures came in at -$22.5 million (Q1 2026), -$21.3 million (Q4 2025), and -$22.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Fractyl Health | 123.81 Mn | 123.81 Mn | - | -15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.90 Mn |
| Jun 30, 2026 | -15.90 Mn |
| Mar 31, 2026 | -22.48 Mn |
| Mar 31, 2026 | -22.48 Mn |
| Dec 31, 2025 | -21.34 Mn |
| Dec 31, 2025 | -21.34 Mn |
| Sep 30, 2025 | -22.72 Mn |
| Sep 30, 2025 | -22.72 Mn |
| Jun 30, 2025 | -21.30 Mn |
| Jun 30, 2025 | -21.30 Mn |
| Mar 31, 2025 | -25.53 Mn |
| Mar 31, 2025 | -25.53 Mn |
| Dec 31, 2024 | -17.27 Mn |
| Dec 31, 2024 | -17.27 Mn |
| Sep 30, 2024 | -18.25 Mn |
| Sep 30, 2024 | -18.25 Mn |
| Jun 30, 2024 | -20.04 Mn |
| Jun 30, 2024 | -20.04 Mn |
| Mar 31, 2024 | -11.73 Mn |
| Mar 31, 2024 | -11.73 Mn |